Cardiovascular
Read More about this categoryShow Less
Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment.
Research Areas
- Acute Phase Reactants(15)
- Angina(14)
- Arrhythmia(82)
- Atherosclerosis(88)
- Chronic Kidney Disease(18)
- Coagulation & Hemostasis(124)
- Coronary Artery Disease(7)
- Diabetic Nephropathy(8)
- Endothelium(33)
- Erythrocytes & Hemoglobin(49)
- Heart Failure(33)
- Hypertension(162)
- Hypotension(24)
- Lipoproteins(61)
- Myocardial Contractility(33)
- Myocardial Hypertrophy(21)
- Myocardial Infarction(61)
- Others(1)
- Serum Proteins(11)
- Smooth Muscle Cells(36)
- Storage & Transport(6)
- Stroke(48)
- Thrombosis(52)
- Vasoconstriction(59)
- Vasodilation(141)
- Cardiomyopathy(5)
- Cholesterol Metabolism(44)
Products Related to Cardiovascular(821)
- GC91424S1PL-IN-31CAS: 1538574-95-6Purity: >98.00%
S1PL-IN-31は、スフィンゴシン-1-リン酸（S1P）ライアーゼの阻害剤であり（IC50 = 210 nM）、です。
- GC91493Semaglutide Side ChainCAS: 1118767-16-0Purity: >98.00%
Semaglutide side chain is a synthetic intermediate.
- GC91497EB 47 (hydrochloride)CAS: 1190332-25-2Purity: >98.00%
EB 47 is an inhibitor of poly(ADP-ribose) polymerase 1 (PARP1; IC50 = 45 nM) and a dual site inhibitor of tankyrase 2 (TNKS2; IC50 = 45 nM).
- GC91544Fmoc-L-Lys[Oct-(OtBu)-Glu-(OtBu)-AEEA-AEEA]-OHCAS: 1662688-20-1Purity: >99.50%
Fmoc-L-Lys[Oct-(OtBu)-Glu-(OtBu)-AEEA-AEEA]-OH is a building block in the synthesis of the glucagon-like peptide 1 receptor (GLP-1R) agonist semaglutide .
- GC91639Ferrous trisglycinateCAS: 34369-82-9Purity: >95.00%
Ferrous trisglycinate is an iron amino acid chelate.
- GC916804-Acetamido AntipyrineCAS: 83-15-8Purity: >95.00%
4-Acetamido antipyrine (4-AAAP) is an active metabolite of the non-opioid analgesic and antipyretic prodrug metamizole .
- GC91889L-Tyrosine (sodium salt hydrate)Purity: >98.00%
L-Tyrosine (sodium salt hydrate)は条件付き必須アミノ酸です。
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC91053 | RM 133-3 | 2941228-90-4 | >95.00% | |
イオン化可能な陽イオン性脂質 | ||||
| GC91065 | (±)13,14-EDT | 355016-19-2 | >98.00% | |
アドレニック酸の代謝産物 | ||||
| GC91067 | (±)16,17-EDT | 351533-79-4 | >98.00% | |
アドレニック酸の代謝産物 | ||||
| GC91083 | Tiopronin-Cysteine Disulfide | 77591-18-5 | >95.00% | |
チオプロニンの代謝物 | ||||
| GC91100 | UCL-TRO-1938 | 2919575-27-0 | >98.00% | |
アロステリックPI3Kα活性化剤 | ||||
| GC91109 | 17β-Estradiol 3-O-Sulfate (sodium salt) | 4999-79-5 | >98.00% | |
17β-エストラジオールの不活性代謝物 | ||||
| GC91136 | XY-4 | 474329-47-0 | >95.00% | |
PPARγのアゴニスト | ||||
| GC91141 | DXR Inhibitor 11a (sodium salt) | - | >98.00% | |
「P. falciparum」のDXR阻害剤 | ||||
| GC91223 | Brain Natriuretic Peptide-32 (rat) (acetate) | - | >98.00% | |
ナトリウム利尿ペプチド | ||||
| GC91229 | DXR Inhibitor 11a (free acid) | 2260608-07-7 | >98.00% | |
「P. falciparum」のDXR阻害剤 | ||||
| GC91410 | RA-2 | 1867107-62-7 | >95.00% | |
RA-2は、小型伝導カルシウム活性化カリウムチャネル2.3（KCa2.3 / SK3）および中間伝導カルシウム活性化カリウムチャネル3.1（KCa3.1 / IK1）の阻害剤です（それぞれIC50値は2nMと17nMです）。 | ||||
| GC91424 | S1PL-IN-31 | 1538574-95-6 | >98.00% | |
S1PL-IN-31は、スフィンゴシン-1-リン酸（S1P）ライアーゼの阻害剤であり（IC50 = 210 nM）、です。 | ||||
| GC91472 | Tat-Gap 19 (trifluoroacetate salt) | - | >95.00% | |
Tat-Gap 19は、コネキシン43（Cx43）ヘミチャネルのペプチド阻害剤です。 | ||||
| GC91493 | Semaglutide Side Chain | 1118767-16-0 | >98.00% | |
Semaglutide side chain is a synthetic intermediate. | ||||
| GC91497 | EB 47 (hydrochloride) | 1190332-25-2 | >98.00% | |
EB 47 is an inhibitor of poly(ADP-ribose) polymerase 1 (PARP1; IC50 = 45 nM) and a dual site inhibitor of tankyrase 2 (TNKS2; IC50 = 45 nM). | ||||
| GC91544 | Fmoc-L-Lys[Oct-(OtBu)-Glu-(OtBu)-AEEA-AEEA]-OH | 1662688-20-1 | >99.50% | |
Fmoc-L-Lys[Oct-(OtBu)-Glu-(OtBu)-AEEA-AEEA]-OH is a building block in the synthesis of the glucagon-like peptide 1 receptor (GLP-1R) agonist semaglutide . | ||||
| GC91615 | AZD 5462 | 2787501-83-9 | >98.00% | |
AZD 5462 is an agonist of relaxin family peptide receptor 1 (RXFP1). | ||||
| GC91639 | Ferrous trisglycinate | 34369-82-9 | >95.00% | |
Ferrous trisglycinate is an iron amino acid chelate. | ||||
| GC91680 | 4-Acetamido Antipyrine | 83-15-8 | >95.00% | |
4-Acetamido antipyrine (4-AAAP) is an active metabolite of the non-opioid analgesic and antipyretic prodrug metamizole . | ||||
| GC91889 | L-Tyrosine (sodium salt hydrate) | - | >98.00% | |
L-Tyrosine (sodium salt hydrate)は条件付き必須アミノ酸です。 | ||||
| GC91898 | BI SF3 (hydrochloride) | 1801257-24-8 | >95.00% | |
BI SF3 (hydrochloride)は合成中間体である。 | ||||
| GC91910 | Ferroptosis Inhibitor D1 | - | >98.00% | |
Ferroptosis Inhibitor D1はラジカル除去剤と鉄垂下抑制剤である。 | ||||
| GC91915 | ZG-2033 | 2685739-28-8 | >98.00% | |
ZG-2033は、酸欠誘導因子2α（HIF−2α）のアゴニストである。 | ||||
| GC91933 | E17241 | 1060968-92-4 | >95.00% | |
E17241はATP結合カセット輸送タンパク質1をコードする遺伝子ABCA 1発現の誘導剤である、サブファミリーA（ABCA 1）。 | ||||